Fresenius Kidney Care Concho Valley, Llc is a medicare approved dialysis facility center in San Angelo, Texas and it has 24 dialysis stations. It is located in Tom Green county at 2018 Pulliam Street, San Angelo, TX, 76905. You can reach out to the office of Fresenius Kidney Care Concho Valley, Llc at (325) 481-0798. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Kidney Care Concho Valley, Llc has the following ownership type - Profit. It was first certified by medicare in August, 2017. The medicare id for this facility is 672834 and it accepts patients under medicare ESRD program.
| Name | Fresenius Kidney Care Concho Valley, Llc |
|---|---|
| Location | 2018 Pulliam Street, San Angelo, Texas |
| No. of Dialysis Stations | 24 |
| Medicare ID | 672834 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2018 Pulliam Street, San Angelo, Texas, 76905 | |
| (325) 481-0798 | |
| Not Available |
News Archive
Racial And Ethnic Disparities In Colorectal Cancer Screening Persisted Despite Expansion Of Medicare's Screening Reimbursement. This study looked at the effect in minority groups of expanded reimbursements by Medicare for colorectal cancer screenings.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that the VA Palo Alto Health Care System, a northern California based hospital group that is part of The Department of Veterans Affairs nationwide network of hospitals, recently purchased 15 Zargis Cardioscan systems.
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
Repligen Corporation announced today that it has acquired the assets of BioFlash Partners, LLC, (BioFlash) including a technology platform for the production of pre-packed, "plug and play" chromatography columns. This patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced it has secured $49 million in an oversubscribed Series D round of financing.
› Verified 7 days ago
| NPI Number | 1881118693 |
| Organization Name | Fresenius Kidney Care San Angelo |
| Doing Business As | Fresenius Kidney Care Concho Valley, Llc |
| Address | 2018 Pulliam St San Angelo, Texas, 76905 |
| Phone Number | (325) 659-7360 |
News Archive
Racial And Ethnic Disparities In Colorectal Cancer Screening Persisted Despite Expansion Of Medicare's Screening Reimbursement. This study looked at the effect in minority groups of expanded reimbursements by Medicare for colorectal cancer screenings.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that the VA Palo Alto Health Care System, a northern California based hospital group that is part of The Department of Veterans Affairs nationwide network of hospitals, recently purchased 15 Zargis Cardioscan systems.
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
Repligen Corporation announced today that it has acquired the assets of BioFlash Partners, LLC, (BioFlash) including a technology platform for the production of pre-packed, "plug and play" chromatography columns. This patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced it has secured $49 million in an oversubscribed Series D round of financing.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.